Oct 15, 2023
Are you interested in exploring cutting-edge autoimmune
medicines? In this episode of BioTalk with Rich Bendis, we're
delving deep into the world of transformative therapies with two
remarkable guests, Dr. Chris Chapman and Dr. Adam Kaplin, from MyMD
Pharmaceuticals.
MyMD Pharmaceuticals is on a mission to make that a reality. Their
lead clinical candidate, MYMD-1®, has the potential to reshape the
entire field.
But how does MYMD-1 work, and what sets it apart from current
treatments? Join us as we unravel the science behind this
revolutionary therapy and explore the potential indications and
patient populations it could benefit.
And that's not all. We also spotlight Supera-CBD, a novel synthetic
cannabidiol with incredible potency and anti-inflammatory effects.
How could this innovation change the landscape of chronic pain and
anxiety management?
Don't miss this episode of BioTalk with Rich Bendis as we embark on
a journey into the future of autoimmune medicine with MyMD
Pharmaceuticals. Tune in now and be part of the conversation.